CrushSCI.com
76.3平均天数
74.5中位天数
34最短天数
139最长天数
1,2562025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

86 天

A lidocaine dry powder inhaler to modulate cough: particle engineering and human proof-of-concept

作者
Giada Varacca; Diletta Mandrioli; Fabio Sonvico; Federico Lavorini; Giovanni Fontana; Alessandra Sorano; Giulia Fabietti; Ruggero Bettini; Francesca Buttini展开收起
作者单位
Food and Drug Department, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy; Interdepartmental Centre for Innovation in Health Products, Biopharmanet_TEC, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy; Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134 Florence, Italy展开收起
PDF源文件 DOI 网页
139 天

Ultrasound-guided spatial delivery based on acoustic bacteria to enhance cancer immunotherapy

作者
Haitao Wu; Bowen Lin; Yueyuan Wang; Chaonan Zhang; Haiyan Wu; Minghao Li; Xuan Liu; Zhen Ya; Shizhe An; Mingxi Wan; Yujin Zong展开收起
作者单位
Key Laboratory of Biomedical Information Engineering of Ministry of Education, Department of Biomedical Engineering, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, China; Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China; Institute for Regenerative Medicine, State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200123, China展开收起
PDF源文件 DOI 网页
75 天

In vitro-in silico framework for evaluating intra-subject variability in the oral absorption of BCS class 1 drugs mediated by the gastric interdigestive migrating motor complex

作者
Takeyuki Okudaira; Shinji Kizuki; Toshihide Takagi; Shinji Yamashita展开收起
作者单位
Formulation Research DP Development Taiho Pharmaceutical Co., Ltd., 224-2, Ebisuno, Hiraishi, Kawauchi-cho, Tokushima 771-0194, Japan; Formulation Research Biologics Process Development Taiho Pharmaceutical Co., Ltd., 3, Okubo, Tsukuba, Ibaraki 300-2611, Japan; Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan; Research Organization of Science and Technology, Ritsumeikan University, 1-1-1 Noji-higashi, Kusatsu, Shiga 525-8577, Japan展开收起
PDF源文件 DOI 网页
74 天

A bioengineered 3D fibrous plaque microsystem for evaluating multimodal nanotherapy in atherosclerosis

作者
Yatian Fu; Mohamed Elhousseini Hilal; Wang Guo; Ke Huang; Wei Li; Sander Dekyvere; Zhiqiang Ma; Junchen Liao; Somboon Chaemchuen; Yang Sylvia Liu; Song Lin Chua; Francis Verpoort; Bee Luan Khoo展开收起
作者单位
Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, China; Hong Kong Centre for Cerebro-cardiovascular Health Engineering, Hong Kong, China; State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Luoshi Road 122, Wuhan 430070, China; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China; State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong, China; Shenzhen Key Laboratory of Food Biological Safety Control, The Hong Kong Polytechnic University, Hong Kong, China; Joint Institute of Chemical Research (FFMiEN), Peoples Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya Str., 117198 Moscow, Russia; Department of Precision Diagnostic and Therapeutic Technology, City University of Hong Kong, Shenzhen-Futian Research Institute, Shenzhen 518057, China展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。